Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence
about
Targeting Notch to overcome radiation resistanceBrain tumor stem cells: Molecular characteristics and their impact on therapyThe novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanomaNOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitroA Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survivalProtective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence.Notch signaling activation in pediatric low-grade astrocytomaNa/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells.Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.Quantitative MRI establishes the efficacy of PI3K inhibitor (GDC-0941) multi-treatments in PTEN-deficient mice lymphomaAnalysis of SOX2-Regulated Transcriptome in Glioma Stem CellsMetformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.Biological and clinical implications of cancer stem cells in primary brain tumors.Synergistic effect of the γ-secretase inhibitor PF-03084014 and docetaxel in breast cancer models.Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockadeThe Notch signaling pathway as a mediator of tumor survivalMolecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation.RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence.Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma.ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis.Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedulesA high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.Cancer stem cells in glioma: challenges and opportunities.EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.Notch signalling in solid tumours: a little bit of everything but not all the time.Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.Glioma stem cells: turpis omen in nomen? (The evil in the name?).The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.Notching on Cancer's Door: Notch Signaling in Brain Tumors.Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.Lateral inhibition of Notch signaling in neoplastic cells.PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth.Fatty acid binding protein 7 as a marker of glioma stem cells.MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion.Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastoma.
P2860
Q26771701-557AADC7-7355-4A9F-94B0-BC3280235F8FQ27003138-7BE55B81-667F-4133-976F-DE186A0126E1Q28744417-766BD290-E015-4DE5-B2B4-E78EF134A59EQ33739238-EC88D1B0-F30C-44BE-92FC-5D129814D89DQ34361366-C7E6C072-A307-492E-8858-A3797CEBB2A1Q34603835-9EA18CF4-51DF-43E0-A69C-8BE741D92071Q35048997-10B2E5D1-040C-4ECF-9F42-B9D14765F99DQ35170287-F0ECC123-3FCB-4EB7-B155-BF03F13511EBQ35213330-12F13F54-1849-443F-8025-2F50476FCF26Q35521316-C62A33CC-30C9-466F-9DC6-9511CC9DAC0CQ35799358-0881BD93-A5FF-45A5-A40E-7551AF8546D0Q36145048-6A12B4DE-710F-4740-97E0-1A948BD111BBQ36545028-5781B164-12BD-4E43-BDE3-F4254A258BD1Q36562573-1BE0FD10-2B23-42E0-908A-B5A463558832Q36861775-27B5CFBA-64F5-4A4B-A8C4-A70C52E49CFBQ36941324-40383514-F847-4693-B01D-35D0E27A7106Q36971953-0705A46E-3E6C-41B5-9C1C-8F7CF4ADBFA3Q37025965-3292C788-CADA-42BB-927D-8BA17C95BE7AQ37042217-574CDFA4-123D-44F1-8E99-143C717083BAQ37132697-50A2D601-EDAC-4A4D-967C-96529ECB24EBQ37419856-40D8B97A-A226-4AAC-9163-2F5C66EB148AQ37520199-CC496047-E859-4C7D-92AB-9C8EB9240F78Q37536711-6AA629E4-3554-4D27-ADEA-9BB5BF81EB21Q37581947-4CAC0076-D246-46A8-A17A-7A6E28DAE30BQ37626395-FA26B9A1-5DEA-4B08-9AA5-A5D1996B9383Q37634973-463724DF-F1F9-4A25-AB55-2B8901FAD6F5Q37660295-BF24D0DC-122E-446B-BFC7-B608511B51F4Q37867484-D7C0FB71-788F-4E42-9ED3-E1A9DAD6B58DQ38021521-467A7953-F78C-4A96-B30D-D67FF696B38CQ38202702-74B5A14B-CD1A-4021-9DBB-2B4F68C9911CQ38287226-2399D300-971E-419C-A6D7-0296D909105AQ38324552-AC34934D-B929-4400-9AFF-F77D102F7128Q38911461-2342082A-1A10-4243-B5ED-DFFDD141D5A3Q38923462-80C145FF-FD5D-476F-9F3F-9DF6CD39545BQ38926314-A46491AB-CDAA-4C86-A6AC-BD99B90C90E9Q38944343-D2B81BAE-FCE5-4116-A44D-F4547D931139Q39055315-74E389A7-C076-45D1-A13D-DDA6A4B04AE6Q39128804-DBFE8900-A74C-4B04-B606-DD5DDED9ADA6Q39136332-0190F3E4-C76B-4D03-A8FD-A686317D8C0FQ39197715-4CDA0EB1-B47C-4596-9E4E-AAC0B8C04B35
P2860
Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@ast
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@en
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@nl
type
label
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@ast
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@en
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@nl
prefLabel
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@ast
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@en
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@nl
P2093
P2860
P1433
P1476
Gamma-secretase inhibitors enh ...... ation and xenograft recurrence
@en
P2093
Alonzo H Ross
Candace A Gilbert
Marie-Claire Daou
Richard P Moser
P2860
P304
P356
10.1158/0008-5472.CAN-10-1378
P407
P577
2010-08-24T00:00:00Z